We believe that Corning stock (NYSE: GLW) is currently a better pick West Pharmaceutical Services stock (NYSE: WST), a global solutions provider for drugs, biologics, gene therapies, and consumer healthcare products. Although these companies are from different sectors, we compare them because they have a similar market capitalization of around $30 billion.
Interestingly, GLW has had a Sharpe Ratio of 0.2 since early 2017, lower than the 0.9 figure for WST and 0.6 for the S&P 500 Index over the same period. This compares with the Sharpe of 1.3 for the Trefis Reinforced Value portfolio. Sharpe is a measure of return per unit of risk, and high-performance portfolios can provide the best of both worlds.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.